Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs-Reference-Cited by-同舟云学术

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs

Published:2012-07-18 Issue:2 Volume:1 Page:172-198
ISSN:2073-4468
Container-title:Antibodies
language:en
Short-container-title:Antibodies

Author:

Stamova Slava,Koristka Stefanie,Keil Juliane,Arndt Claudia,Feldmann Anja,Michalk Irene,Bartsch Holger,Bippes Claudia C.,Schmitz Marc,Cartellieri Marc,Bachmann Michael

Publisher

MDPI AG

Subject

Drug Discovery,Immunology,Immunology and Allergy

Link

http://www.mdpi.com/2073-4468/1/2/172/pdf

Reference177 articles.

1. Ueber den jetzigen stand der Karzinomforschung;Ehrlich;Ned. Tijdschr. Geneeskd.,1909

2. Cancer--A Biological Approach: I. The Processes Of Control. II. The Significance of Somatic Mutation

3. Reactions to homologous tissue antigens in relation to hypersensitivity [Discussion];Thomas,1959

4. Cancer immunoediting: from immunosurveillance to tumor escape

5. Cancer immunotherapy: The past, the present and the future

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy;Frontiers in Immunology;2023-06-27

2. A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells;Frontiers in Immunology;2023-06-13

3. Natural killer cell immunotherapy in glioblastoma;Discover Oncology;2022-10-28

4. Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells;International Journal of Molecular Sciences;2022-07-18

5. Recent advances and challenges of bispecific antibodies in solid tumors;Experimental Hematology & Oncology;2021-12